The `Experimental Stable' of the BCG Vaccine: Safety, Efficacy, Proof, and Standards, 1921--1933 (2005)
Bonah, Christian (Author)
Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences
Volume: 36
Pages: 696--721
Edition Details: Part of special issue: “Drug Trajectories”
Language: English
The anti-tuberculosis BCG (Bacille Calmette-Guérin) vaccine was conceived and developed between 1905 and 1921 at Pasteur Institutes in France. Between 1921 and A. Calmette's death in 1933, the vaccine went through a first period of national and international production and distribution for its use in humans. In France these activities were exclusively carried out by Calmette and his collaborators at the Pasteur Institute in Paris. Initially improvised production in a small room in the cellar gave way in 1931 to the construction of the spacious and magnificent `New laboratories for research on tuberculosis and the preparation of the BCG' within the premises of the Pasteur Institute. Presentation and image-building of the vaccine in France insisted on the fact that the BCG was not a commercial specialty but distributed free of charge. The technical monopoly of its production nevertheless lay with the Paris Pasteur Institute and standardization of scientific proof of safety, efficacy and stability was dominated by that Institute in France. In contrast, the international production and distribution of the vaccine was entrusted and transferred, free of charge, to trustworthy laboratories outside France. Multiplication of producers and users led to an increased need for standardization. For this process the analysis distinguishes between the standardization of scientific proof concerning safety, efficacy and stability of the vaccine and standardization of its medical uses. Whereas standardization was rather successful in the inter-war period in France, the international efforts remained rather unsuccessful. Only after world war II under Scandinavian leadership and in the context of mass vaccination programs supported by the WHO and UNICEF was the international standardization effectively implemented and succeeded at least to some extend.
...MoreArticle Gaudillière, Jean-Paul (2005) Introduction: Drug Trajectories. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences (p. 603).
Similar Citations
Article
Lukas Engelmann;
(2021)
An Epidemic for Sale: Observation, Modification, and Commercial Circulation of the Danysz Virus, 1890–1910
(/isis/citation/CBB194783319/)
Article
Debue-Barazer, Christine;
(2007)
Les implications scientifiques et industrielles du succès de la Stovaïne®. Ernest Fourneau (1872--1949) et la chimie des médicaments en France
(/isis/citation/CBB000800283/)
Article
Hawgood, Barbara J.;
(2007)
Albert Calmette (1863--1933) and Camille Guérin (1872--1961): The C and G of BCG Vaccine
(/isis/citation/CBB000831643/)
Article
McMillen, Christian W.;
(2008)
“The Red Man and the White Plague”: Rethinking Race, Tuberculosis, and American Indians, ca. 1890--1950
(/isis/citation/CBB000930711/)
Thesis
David, Michael Zdenek;
(2007)
The White Plague in the Red Capital: The Control of Tuberculosis in Russia,1900--1941
(/isis/citation/CBB001561353/)
Article
Bonah, Christian;
(2008)
Packaging BCG: Standardizing an Anti-Tuberculosis Vaccine in Interwar Europe
(/isis/citation/CBB000831750/)
Article
Simon, Jonathan;
(2007)
The Origin of the Production of Diphtheria Antitoxin in France, between Philanthropy and Commerce
(/isis/citation/CBB000820146/)
Article
Opinel, Annick;
(2008)
The Emergence of French Medical Entomology: The Influence of Universities, the Institut Pasteur and Military Physicians (1890--c. 1938)
(/isis/citation/CBB000931174/)
Article
Simon, Jonathan;
(2008)
Monitoring the Stable at the Pasteur Institute
(/isis/citation/CBB000831746/)
Article
Gaudillière, Jean-Paul;
Gausemeier, Bernd;
(2005)
Molding National Research Systems: The Introduction of Penicillin to Germany and France
(/isis/citation/CBB000610604/)
Article
Hage, Jerald;
Mote, Jonathon;
(2010)
Transformational Organizations and a Burst of Scientific Breakthroughs: The Institut Pasteur and Biomedicine, 1889--1919
(/isis/citation/CBB001231858/)
Book
Thomas Goetz;
(2014)
The Remedy: Robert Koch, Arthur Conan Doyle, and the Quest to Cure Tuberculosis
(/isis/citation/CBB213980885/)
Article
Lei, Sean Hsiang-lin;
(2010)
Habituating Individuality: The Framing of Tuberculosis and Its Material Solutions in Republican China
(/isis/citation/CBB001031258/)
Article
Hähner-Rombach, Sylvelyn;
(2014)
Anforderungen in der ambulanten Versorgung: Das Beispiel der Tuberkulosefürsorgerinnen im ersten Drittel des 20. Jahrhunderts
(/isis/citation/CBB001421916/)
Article
Dale, Pamela;
Greenlees, Janet;
Melling, Joseph;
(2007)
The Kiss of Death or a Flight of Fancy? Workers' Health and the Campaign to Regulate Shuttle Kissing in the British Cotton Industry, c. 1900--52
(/isis/citation/CBB001030541/)
Chapter
Gausemeier, Bernd;
(2013)
Borderlands of Heredity: The Debate about the Hereditary Susceptibility to Tuberculosis, 1882--1945
(/isis/citation/CBB001500049/)
Book
Jones, Greta;
Malcolm, Elizabeth;
(1999)
Medicine, disease, and the State in Ireland, 1650-1940
(/isis/citation/CBB000110599/)
Book
Wolters, Christine;
(2011)
Tuberkulose und Menschenversuche im Nationalsozialismus: Das Netzwerk hinter den Tbc-Experimenten im Konzentrationslager Sachsenhausen
(/isis/citation/CBB001202027/)
Article
García Ferrandis, Xavier;
(2013)
Epidemiological and Care Aspects of Tuberculosis in Valencia during the Spanish Civil War and the Immediate Postwar Period (1936-1941)
(/isis/citation/CBB001200191/)
Article
Antunes, José Leopoldo Ferreira;
Moraes, Mirtes de;
Biazevic, Maria Gabriela Haye;
Waldman, Eliseu Alves;
Corrêa, Marcelo Oswaldo Alvares;
(2002)
Tuberculose e leite: elementos para a história de uma polêmica
(/isis/citation/CBB000300952/)
Be the first to comment!